Few drug researchers report possible financial conflicts; Inspector General faults FDA (Canadian Business)

Missing information, loopholes and weak oversight hamper efforts to uncover financial conflicts by researchers who test experimental drugs before

Read more here: 
Few drug researchers report possible financial conflicts; Inspector General faults FDA (Canadian Business)